Methotrexate Pathway
Nov. 5, 2024
Methotrexate Pathway (Cancer Cell), Pharmacodynamics and Pharmacokinetics Frontiers | The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis Frontiers | Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia Methotrexate Pathway
![PDF] New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotr…](https://d3i71xaburhd42.cloudfront.net/da859cfe821765f67ab928ce2b213672a5d4f50d/2-Figure1-1.png){kind=link}
![PDF] Understanding the mechanisms of action of methotrexate: implications for the t…](https://d3i71xaburhd42.cloudfront.net/df76cd7de14e79a6a96b08727c84e6631b157e8c/2-Figure1-1.png){kind=link}
![leucovorin [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/leucovorin.png){kind=link}
